Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Going Home (A short film on Dementia)

vci1 - penn medicine1 - creutzfeldt-jakob disease5 - psychotic symptoms1 - alzheimers patients3 - lewy body dementia2 - disinhibition1 - fischer1 - cerebrospinal fluid8 - fragmentation of dementia1 - amnestic mild cognitive impairment1 - cyclophilin a1 - memory impairments1 - niaiserie1 - ipscs1 - diagnose parkinson's1 - blood vessels1 - myxoedema1 - symptomatic benefit1 - frontotemporal degeneration1 - sunflower oil1 - alcoholism1 - stepfamily1 - mitochondria1 - neuronix1 - dopaminergic neurons1 - risk of dementia12 - alzheimers disease center1 - depressive pseudodementia1 - abstract thinking1 -